glp-1 and osteoporosis Frontiers Losing weight on GLP-1, but
Description
The approval is based on the ADHERE study, where 69% of patients treated with Vyvgart Hytrulo regardless of prior treatment saw evidence of clinical improvement, including improvements in mobility, function and strength
The critical rule is maintaining a minimum gap between injections
Activation there reduces food intake, and it is this central action, as much as any peripheral effect, that drives the weight loss seen with GLP-1 drugs
This medication is specifically targeted at individuals needing medical assistance to achieve significant long-term weight loss
GLP-1 medications can lead to significant weight loss, especially when paired with healthy eating and regular physical activity as part of comprehensive lifestyle changes
The strengths include that over a thousand consecutive patients were examined, and a comprehensive list of confounders was studied in our dataset
